Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Dec 1;12(6):963-965.
doi: 10.21037/hbsn-23-552. Epub 2023 Nov 15.

The vascular endothelial growth factor system-a new player in the pathogenesis and development of metabolic dysfunction-associated steatotic liver disease

Henning Grønbæk  1   2 , Anders Mellemkjær  1   2 , Søren Nielsen  2   3 , Faidon Magkos  4
Affiliations
Editorial

The vascular endothelial growth factor system-a new player in the pathogenesis and development of metabolic dysfunction-associated steatotic liver disease

Henning Grønbæk et al. Hepatobiliary Surg Nutr. .
No abstract available

Keywords: Vascular endothelial growth factor B (VEGF-B); metabolic dysfunction-associated steatotic liver disease (MASLD); non-alcoholic fatty liver disease (NAFLD).

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://hbsn.amegroups.com/article/view/10.21037/hbsn-23-552/coif). H.G. has received research grants from Abbvie, Intercept, ARLA Food for health, and ADS AIPHIA Development Services, AG, Switzerland, consulting fees from AstraZeneca, NOVO, Pfizer and he is member of Data Monitoring Board CAMURUS. The other authors have no conflicts of interest to declare.

Comment on

References

    1. Falkevall A, Mehlem A, Folestad E, et al. Inhibition of VEGF-B signaling prevents non-alcoholic fatty liver disease development by targeting lipolysis in the white adipose tissue. J Hepatol 2023;78:901-13. 10.1016/j.jhep.2023.01.014 - DOI - PubMed
    1. Flessa CM, Nasiri-Ansari N, Kyrou I, et al. Genetic and Diet-Induced Animal Models for Non-Alcoholic Fatty Liver Disease (NAFLD) Research. Int J Mol Sci 2022;23:15791. 10.3390/ijms232415791 - DOI - PMC - PubMed
    1. Hansen HH, Ægidius HM, Oró D, et al. Human translatability of the GAN diet-induced obese mouse model of non-alcoholic steatohepatitis. BMC Gastroenterol 2020;20:210. 10.1186/s12876-020-01356-2 - DOI - PMC - PubMed
    1. Osorio-Conles Ó, Vega-Beyhart A, Ibarzabal A, et al. A Distinctive NAFLD Signature in Adipose Tissue from Women with Severe Obesity. Int J Mol Sci 2021;22:10541. 10.3390/ijms221910541 - DOI - PMC - PubMed
    1. Kazankov K, Jørgensen SMD, Thomsen KL, et al. The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Nat Rev Gastroenterol Hepatol 2019;16:145-59. 10.1038/s41575-018-0082-x - DOI - PubMed